FORT WORTH, Texas--(BUSINESS WIRE)--NanOlogy LLC, a clinical-stage interventional oncology drug company, announced enrollment is complete in a Phase 2a trial of intratumoral (IT) large surface area ...
FORT WORTH, Texas--(BUSINESS WIRE)--NanOlogy LLC, a clinical-stage interventional oncology drug company, announced today publication of a research article entitled Early Phase Trial of Intracystic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback